Raymond James analyst C. Gregory Peters reiterated his Outperform rating on Health Insurance Innovations and raised his price target on shares to $55 from $38, saying he is encouraged by management’s views that an agreement with regulators related to the multistate examination may potentially be reached in Q3. The analyst added that he believes the company is positioned to handle a potential fine, given its substantial cash position.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.